New ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group

In 2015 the European Society of Cardiology published a new version of the guidelines for the management of acute coronary syndromes without persistent ST-segment elevation. The current communication addresses some of the most important updates: introduction of the 1-hour diagnostic algorithm with high-sensitivity troponin assays, specified time lines for the invasive strategy, new recommendatio...

Comments on the ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology.

doi: 10.1016/j.rec.2011.12.004 The new guidelines for the management of acute coronary syndrome in patients without persistent ST-elevation (NSTE-ACS),1 prepared in 2011 by the European Society of Cardiology (ESC), have been accepted by the Spanish Society of Cardiology (SEC) and translated to Spanish for publication in their entirety in the Revista Española de Cardiología2. As a support tool f...

Questions and answers on coronary revascularization: a companion document of the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands, Istituto di Farmacologia, Università Cattolica del Sacro Cuore, Rome, Italy, Institut de Cardiologie, Groupe Hospitalier Pitié-Salpetrière, Paris, France, Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital, Basel, Switzerland, Division of Cardiology, University Hospital, Geneva, Switz...

The management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: early invasive strategy for all?

It is unquestionable that early invasive reperfusion therapy in the setting of ST-segment elevation myocardial infarction (STEMI) has significantly reduced infarct-related mortality and morbidity [1]. Scientific and social dissemination campaigns have created a certain awareness both in the public domain and among physicians with slogans such as ‘the sooner the better’ and ‘time is muscle’, whe...

CardioPulse: What's new in the 2015 European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.